Sol-Gel Technologies Total Current Liabilities 2016-2024 | SLGL

Sol-Gel Technologies total current liabilities from 2016 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Sol-Gel Technologies Total Current Liabilities 2016-2024 | SLGL

Sol-Gel Technologies total current liabilities from 2016 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$20.1B
Dr Reddy's Laboratories (RDY)$13.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M